However, the role of GRB2 in receptor tyrosine kinase- or Ser/Thr kinase-activated signalling such as TGF-β in NSCLC or SCLC has thus far still not been clearly elucidated. This evidence concerns the gene GRB2 and non-small cell lung carcinoma.